Randomised controlled trial of combined cognitive behavioural therapy for alcohol use problems and social phobia

Not yet recruiting

Conditions: comorbid Social anxiety disorder and alcohol use disorder
Mental Health - Anxiety
Mental Health - Addiction

Registration Number: ACTRN12608000228381

Lead Sponsor: Dr Andrew Baillie

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Not yet recruiting

Sex: All

Target Recruitment: 200

Inclusion Criteria

adults (aged 18 years and older) who consume alcohol at harmful levels (men consuming 29 standard drinks of alcohol per week or more and women 14 standard drinks per week or more) and have a current (DSM-IV) diagnosis of social phobia; have a basic literacy and ability to communicate in English

Exclusion Criteria

Active or florid psychosis,
History of schizophrenia spectrum disorder or bipolar disorder,
Current active suicidal intent,
Current injecting drug use,
Dependence on benzodiazepines or other substances (other than tobacco)
Need for intensive detoxification (a score = 20 on CIWA-AR) (upon completion of detoxification participants will be eligible for inclusion),
Inability to provide locator information or inability to participate in treatment and booster sessions

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Symptoms of social anxiety disorder as assessed by a composite of the Social Phobia Scale and Social Interaction Anxiety scale, Brief Fear of Negative Evaluation Scale, and Social Phobia subscale of the Albany Panic and Phobia Questionnaire[3 and six months post treatment];Symptoms of Alcohol use disorders, alcohol consumption, alcohol related problems, alcohol dependence as assessd by the number of tandard drinks per drinking occasion, assessed using the Time Line Follow Back procedure, and the Severity of Alcohol Dependence Questionnaire.[three and six months post treatment];Quality of Life as assessed by the Short Form 12 (SF-12)[three and six months post treatment]

Secondary Outcome Measures